Streetbeat News

Stock Prices

CHGG

COUR

MED

YUMC

Medifast reported mixed Q1 results, missing EPS estimates but beating sales expectations, leading to a 15.6% pre-market drop. Coursera, Chegg, ADC Therapeutics, Mesoblast, Coeur Mining, Prudential, Yum China, Sibanye Stillwater, and Rambus also saw pre-market declines due to various factors including disappointing financial results, leadership changes, and clinical trial updates.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 10:07 am

ACIW

ACI Worldwide has updated its 2024 revenue guidance to a range of $1.547B-$1.581B, an increase from the previous range of $1.547B-$1.576B, surpassing the consensus estimate of $1.56B.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:05 am

THRM

Gentherm projects its FY24 revenue to be between $1.5 billion and $1.6 billion, aligning closely with the estimated $1.55 billion.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:04 am

NOG

Northern Oil & Gas (NOG) reported Q1 2024 adjusted EPS of $1.28, surpassing the $1.19 estimate, and sales of $532.041M, exceeding the $506.932M estimate. This represents a 27.27% decrease in EPS and a 24.82% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:03 am

ACIW

ACI Worldwide (NASDAQ:ACIW) reported Q1 2024 adjusted EPS of $0.10, surpassing the $(0.18) estimate, with a 155.56% beat. Year-over-year, this represents a 242.86% increase from a $(0.07) loss per share. Quarterly sales reached $316.019M, exceeding the $306.263M forecast by 3.19% and marking a 9.09% increase from $289.676M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:03 am

ARCB

ArcBest (NASDAQ:ARCB) reported Q1 earnings of $1.34 per share, missing the consensus estimate of $1.53, and sales of $1.04B, slightly above the $1.03B estimate. Earnings per share decreased by 15.19% and sales by 6.33% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:03 am

THRM

Gentherm (NASDAQ:THRM) reported Q1 adjusted earnings of $0.62 per share, surpassing the $0.43 estimate, marking a 44.19% beat and a 26.53% increase from last year's $0.49. However, their Q1 sales of $356.01M fell short of the $358.53M estimate by 0.70%, and saw a 2.09% decrease from the previous year's $363.63M.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:02 am

IT

Gartner (NYSE:IT) reported Q1 2024 adjusted EPS of $2.93, surpassing the $2.53 estimate, marking a 15.81% beat and a 1.74% increase from last year's $2.88. However, their sales of $1.473B slightly missed the $1.475B estimate by 0.11%, though it's a 4.54% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:01 am

APD

Air Products & Chemicals (APD) reported Q2 2024 adjusted EPS of $2.85, surpassing the $2.69 estimate, marking a 4.01% year-over-year increase. However, their sales of $2.930B fell short of the $3.047B estimate, showing a significant decrease from $3.200B the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:01 am

LDOS

Leidos Holdings (NYSE:LDOS) reported Q1 2024 adjusted EPS of $2.29, surpassing the $1.70 estimate, with sales of $3.975B also beating the $3.818B estimate, marking a 7.46% increase over the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:01 am